Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne
Journal of Drugs in Dermatology · 01.06.2026 · 25 (6) · 545-550
DOI: 10.36849/jdd.9761 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.05.2026. Verfasst von Leon Kircik und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Adapalene, Cortodoxone, Dermatologic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Kircik, L., Lamb, A. J., Kircik, A., Squittieri, N., & Kyeremateng, K. (2026). Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne. Journal of Drugs in Dermatology, 25(6), 545-550. https://doi.org/10.36849/jdd.9761
Vancouver
Kircik L, Lamb AJ, Kircik A, Squittieri N, Kyeremateng K. Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne. Journal of Drugs in Dermatology. 2026;25(6):545-550. doi:10.36849/jdd.9761
BibTeX
@article{Kircik2026,
author = {Kircik, Leon and Lamb, Angela J and Kircik, Aram and Squittieri, Nicholas and Kyeremateng, Kizito},
title = {Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {6},
pages = {545--550},
doi = {10.36849/jdd.9761}
}
EUVIMED